Topical Cannabis for AIMSS: Medical Cannabis Evidence-Based Care
Topical cannabinoids for AIMSS offer a promising approach to managing joint pain and stiffness caused by aromatase inhibitor therapy. Clinical trials show these balms are generally well-tolerated and feasible for use. This evidence-based care option may…
Topical Cannabis for AIMSS: Medical Cannabis Evidence
This study evaluates topical cannabinoid application feasibility in postmenopausal breast cancer patients with AIMSS. The trial found topical cannabis balms to be well tolerated. These results support further research on topical cannabinoid application…
Topical Cannabis Balms for AIMSS: Clinical Trial Data
Topical cannabis balms AIMSS treatment was evaluated in a randomized trial among breast cancer survivors experiencing musculoskeletal pain. The study assessed feasibility, tolerability, and preliminary efficacy of CBD and THC balms. Results provide early…